Skip to main content
. 2023 Aug 28;14:1219252. doi: 10.3389/fphys.2023.1219252

TABLE 4.

Biochemical parameters of the severe COVID-19, moderate COVID-19, and control group in pre- and post-assessment intervention.

Variables Severe Moderate Control
Pre Post Δ% Pre Post Δ% Pre Post Δ%
Fasting glucose (mg/dL) a 101.4 ± 15.8 96.1 ± 11.7 −4.5 95.9 ± 9.4 92.0 ± 13.3 b −6.2 96.9 ± 8.0 88.9 ± 8.6 b −8.3
HbA1C (%) 6.5 ± 0.6 6.1 ± 0.3 −5.9 6.1 ± 0.5 6.1 ± 0.8 −3.6 6.5 ± 0.7 6.1 ± 0.7 −6.3
Total cholesterol (mg/dL) a 175.5 ± 22.4 166.0 ± 23.1 −5.5 177.7 ± 33.2 157.9 ± 33.9 1.1 200.1 ± 44.9 177.1 ± 16.3 b −8.9
HDL-c (mg/dL) a 47.2 ± 6.8 52.1 ± 5.9 b 11.2 54.6 ± 15.1 57.3 ± 12.9 6.2 52.7 ± 14.8 54.0 ± 12.2 3.1
LDL-c (mg/dL) 97.3 ± 23.6 91.3 ± 26.0 −7.2 93.1 ± 25.2 91.1 ± 27.1 −0.8 103.7 ± 26.5 99.1 ± 32.1 0.7
TGL (mg/dL) a 155.1 ± 59.3 112.2 ± 51.8 b −28.2 149.5 ± 79.6 91.0 ± 35.1 b −15.6 179.6 ± 101.6 147.7 ± 74.0 b −31.0
ALT (U/L) 35.8 ± 12.8 28.0 ± 7.6 −19.5 29.0 ± 16.0 29.8 ± 14.2 12.0 37.9 ± 18.9 40.3 ± 19.1 38.5
AST (U/L) 30.7 ± 8.9 27.4 ± 7.2 −6.7 33.0 ± 15.6 29.8 ± 5.8 −4.3 33.6 ± 12.1 38.1 ± 17.7 22.8
ALP (U/L) 63.0 ± 16.7 60.4 ± 20.3 −2.9 67.5 ± 15.1 72.1 ± 16.9 5.6 66.3 ± 12.6 67.4 ± 13.2 4.0
GAMMA-GT (U/L) 44.5 ± 12.6 39.7 ± 9.5 −9.8 38.2 ± 18.3 38.5 ± 17.3 11.7 38.2 ± 16.4 55.1 ± 27.2 45.1
Albumin (g/dL) a 4.1 ± 0.2 4.6 ± 0.2 b 11.9 4.0 ± 0.3 b 4.5 ± 0.1 12.2 4.3 ± 0.3 4.5 ± 0.1 6.1
CRP (mg/L) a 10.1 ± 8.9 2.5 ± 1.7 −56.6 8.9 ± 6.2 3.1 ± 3.2 b −68.4 11.7 ± 4.8 4.0 ± 4.5 b −25.1

Note: data expressed as mean and ±standard deviation; Δ% = relative delta; HDL-c, high-density lipoprotein; LDL-c, low-density lipoprotein; TGL, triglycerides; ALT, alanine aminotransferase; AST, aspartate aminotransferase; ALP, alkaline phosphatase; GAMMA-GT, Gamma-glutamyl transferase; CRP = C-reactive protein; Δ = relative delta.

a

time difference from post-intervention.

b

significant difference between pre− and post-intervention for the same group intervention; significance level established p<0.05.